VPH is an international community driving the adoption of in silico medicine by connecting scientists, industry, clinicians, patients, healthcare providers, regulators, and policymakers for a better and more efficient healthcare.
Countries involved
Institutions involved
Members
Discover more
The U.S. National Institutes of Health (NIH) is highlighting new research opportunities in Digital Twins for Biomedical, Biological, and Behavioral Research, supporting innovative approaches to accelerate scientific discovery and advance healthcare technologies.
As the European Union moves forward with revising Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR), the European Parliament’s Committee on Environment, Public Health and Food Safety (SANT) is taking a central role in recalibrating the MedTech regulatory landscape.
The European Medicines Agency (EMA) has initiated a voluntary pilot testing a revised model for Pre-Submission Interactions (PSI) ahead of initial Marketing Authorisation Applications (MAAs).
